Global Oncology Based In-Vivo CRO Market Size, Share, Trends, Growth and Forecast 2032

Oncology Based In-Vivo CRO Market

Oncology Based In-Vivo CRO Market - By Indication (Solid Tumors, Blood Cancer, Patient-Derived Xenograft, Syngeneic Model, Xenograft, and Others), And By Region - Global Industry Perspective, Comprehensive Analysis, and Forecast, 2024 - 2032

Category: Pharmaceutical Report Format : PDF Pages: 110 Report Code: ZMR-2982 Published Date: Oct-2024 Status : Published
Market Size in 2023 Market Forecast in 2032 CAGR (in %) Base Year
USD 1.39 Billion USD 3.13 Billion 8.5% 2023

Table Of Content

  • Chapter 1. Preface
    • 1.1. Report Description and Scope
    • 1.2. Research Scope
    • 1.3. Research Methodology
      • 1.3.1. Market Research Process
      • 1.3.2. Market Research Methodology
  • Chapter 2. Executive Summary
    • 2.1. Onculogy Based In-Vivo CRO Market, 2015–2025 (USD Billion)
    • 2.2. Onculogy Based In-Vivo CRO Market: Snapshot
  • Chapter 3. Global Onculogy Based In-Vivo CRO Market– Industry Analysis
    • 3.1. Onculogy Based In-Vivo CRO Market: Market Dynamics
    • 3.2. Market Drivers
      • 3.2.1. A surge in the aging population prone to chronic diseases such as cancer is likely to define the expansion of onculogy based in-vivo CRO industry over the forecast timeframe.
      • 3.2.2. Approval of generic medicines by organizations such as U.S. FDA and launch of biosimilars has encouraged the pharma firms to take support of CROs for cancer research & drug development. Such moves will create a strong platform for the growth of the onculogy based in-vivo CRO industry over the assessment period.
    • 3.3. Porter’s Five Forces Analysis
    • 3.4. Market Attractiveness Analysis
      • 3.4.1. Market attractiveness analysis By Indication
  • Chapter 4. Global Onculogy Based In-Vivo CRO Market– Competitive Landscape
    • 4.1. Company market share analysis
      • 4.1.1. Global Onculogy Based In-Vivo CRO Market: company market share, 2018
    • 4.2. Strategic development
      • 4.2.1. Acquisitions & mergers
      • 4.2.2. New Product launches
      • 4.2.3. Agreements, partnerships, cullaborations, and joint ventures
      • 4.2.4. Research and development and Regional expansion
    • 4.3. Price trend analysis
  • Chapter 5. Global Onculogy Based In-Vivo CRO Market– Indication Analysis
    • 5.1. Global Onculogy Based In-Vivo CRO Market overview: By Indication
      • 5.1.1. Global Onculogy Based In-Vivo CRO Market share, By Indication , 2019 and 2025
    • 5.2. Sulid Tumors
      • 5.2.1. Global Onculogy Based In-Vivo CRO Market By Sulid Tumors , 2015–2025 (USD Billion)
    • 5.3. Blood Cancer
      • 5.3.1. Global Onculogy Based In-Vivo CRO Market By Blood Cancer, 2015–2025 (USD Billion)
    • 5.4. Patient-Derived Xenograft
      • 5.4.1. Global Onculogy Based In-Vivo CRO Market By Patient-Derived Xenograft , 2015–2025 (USD Billion)
    • 5.5. Syngeneic Model
      • 5.5.1. Global Onculogy Based In-Vivo CRO Market By Syngeneic Model, 2015–2025 (USD Billion)
    • 5.6. Xenograft
      • 5.6.1. Global Onculogy Based In-Vivo CRO Market By Xenograft, 2015–2025 (USD Billion)
    • 5.7. Others
      • 5.7.1. Global Onculogy Based In-Vivo CRO Market By Others, 2015–2025 (USD Billion)
  • Chapter 6. Company Profiles
    • 6.1. Charles River Laboratory
      • 6.1.1. Overview
      • 6.1.2. Financials
      • 6.1.3. Product Portfolio
      • 6.1.4. Business Strategy
      • 6.1.5. Recent Developments
    • 6.2. Eurofins Scientific
      • 6.2.1. Overview
      • 6.2.2. Financials
      • 6.2.3. Product Portfolio
      • 6.2.4. Business Strategy
      • 6.2.5. Recent Developments
    • 6.3. Crown Bioscience
      • 6.3.1. Overview
      • 6.3.2. Financials
      • 6.3.3. Product Portfolio
      • 6.3.4. Business Strategy
      • 6.3.5. Recent Developments
    • 6.4. ICON Plc.
      • 6.4.1. Overview
      • 6.4.2. Financials
      • 6.4.3. Product Portfolio
      • 6.4.4. Business Strategy
      • 6.4.5. Recent Developments
    • 6.5. The Jackson Laboratory
      • 6.5.1. Overview
      • 6.5.2. Financials
      • 6.5.3. Product Portfolio
      • 6.5.4. Business Strategy
      • 6.5.5. Recent Development
    • 6.6. EVOTEC
      • 6.6.1. Overview
      • 6.6.2. Financials
      • 6.6.3. Product Portfolio
      • 6.6.4. Business Strategy
      • 6.6.5. Recent Development
    • 6.7. Covance
      • 6.7.1. Overview
      • 6.7.2. Financials
      • 6.7.3. Product Portfolio
      • 6.7.4. Business Strategy
      • 6.7.5. Recent Development
    • 6.8. Taconic Biosciences
      • 6.8.1. Overview
      • 6.8.2. Financials
      • 6.8.3. Product Portfolio
      • 6.8.4. Business Strategy
      • 6.8.5. Recent Development
    • 6.9. Wuxi AppTec
      • 6.9.1. Overview
      • 6.9.2. Financials
      • 6.9.3. Product Portfolio
      • 6.9.4. Business Strategy
      • 6.9.5. Recent Development
    • 6.10. Living Tumor Laboratory
      • 6.10.1. Overview
      • 6.10.2. Financials
      • 6.10.3. Product Portfolio
      • 6.10.4. Business Strategy
      • 6.10.5. Recent Development
    • 6.11. MI Bioresearch, Inc.
      • 6.11.1. Overview
      • 6.11.2. Financials
      • 6.11.3. Product Portfolio
      • 6.11.4. Business Strategy
      • 6.11.5. Recent Development
    • 6.12. Xentech
      • 6.12.1. Overview
      • 6.12.2. Financials
      • 6.12.3. Product Portfolio
      • 6.12.4. Business Strategy
      • 6.12.5. Recent Development
    • 6.13. Champion Onculogy, Inc.
      • 6.13.1. Overview
      • 6.13.2. Financials
      • 6.13.3. Product Portfolio
      • 6.13.4. Business Strategy
      • 6.13.5. Recent Development

Table Of Figures

List of Figures

1. Market research process
2. Market research methodology
3. Global Oncology Based In-Vivo CRO Market, 2015–2025 (USD Billion)
4. Porter’s Five Forces Analysis
5. Global Oncology Based In-Vivo CRO Market attractiveness, By Indication  
6. Global Oncology Based In-Vivo CRO Market Share by Indication  ,2019 and 2025 (USD Billion)
7. Global Oncology Based In-Vivo CRO Market by Solid Tumors ,2015–2025 (USD Billion)
8. Global Oncology Based In-Vivo CRO Market by Blood Cancer ,2015–2025 (USD Billion)
9. Global Oncology Based In-Vivo CRO Market by Patient-Derived Xenograft ,2015–2025 (USD Billion)
10. Global Oncology Based In-Vivo CRO Market by Syngeneic Model,2015–2025 (USD Billion)
11. Global Oncology Based In-Vivo CRO Market by Xenograft ,2015–2025 (USD Billion)
12. Global Oncology Based In-Vivo CRO Market by Others ,2015–2025 (USD Billion)
13. Global Oncology Based In-Vivo CRO Market share, by Region, 2019 and 2025
14. North America Oncology Based In-Vivo CRO Market, 2015–2025 (USD Billion)
15. Europe Oncology Based In-Vivo CRO Market, 2015–2025 (USD Billion)
16. Asia Pacific Oncology Based In-Vivo CRO Market, 2015–2025 (USD Billion)
17. Latin America Oncology Based In-Vivo CRO Market, 2015–2025 (USD Billion)
18. The Middle East and Africa Oncology Based In-Vivo CRO Market, 2015–2025 (USD Billion)
 


Table Of Tables

List of Tables

1. Global Oncology Based In-Vivo CRO Market: snapshot
2. Drivers of the Oncology Based In-Vivo CRO Market: impact analysis
3. North America Oncology Based In-Vivo CRO Market revenue, By Indication  , 2015–2025 (USD Billion)
4. The U.S. Oncology Based In-Vivo CRO Market revenue, By Indication  , 2015–2025 (USD Billion)
5. Rest of North America Oncology Based In-Vivo CRO Market revenue, By Indication  , 2015–2025 (USD Billion)
6. Europe Oncology Based In-Vivo CRO Market revenue, By Indication  , 2015–2025 (USD Billion)
7. UK Oncology Based In-Vivo CRO Market revenue, By Indication  , 2015–2025 (USD Billion)
8. France Oncology Based In-Vivo CRO Market revenue, By Indication  , 2015–2025 (USD Billion)
9. Germany Oncology Based In-Vivo CRO Market revenue, By Indication  , 2015–2025 (USD Billion)
10. Rest of Europe Oncology Based In-Vivo CRO Market revenue, By Indication  , 2015–2025 (USD Billion)
11. Asia Pacific Oncology Based In-Vivo CRO Market revenue, By Indication  , 2015–2025 (USD Billion)
12. China Oncology Based In-Vivo CRO Market revenue, By Indication  , 2015–2025 (USD Billion)
13. Japan Oncology Based In-Vivo CRO Market revenue, By Indication  , 2015–2025 (USD Billion)
14. India Oncology Based In-Vivo CRO Market revenue, By Indication  , 2015–2025 (USD Billion)
15. Rest of Asia Pacific Oncology Based In-Vivo CRO Market revenue, By Indication  , 2015–2025 (USD Billion)
16. Latin America Oncology Based In-Vivo CRO Market revenue, By Indication  , 2015–2025 (USD Billion)
17. Brazil Oncology Based In-Vivo CRO Market revenue, By Indication  , 2015–2025 (USD Billion)
18. Rest of Latin America Oncology Based In-Vivo CRO Market revenue, By Indication  , 2015–2025 (USD Billion)
19. The Middle East and Africa Oncology Based In-Vivo CRO Market revenue, By Indication  , 2015–2025 (USD Billion)
20. Saudi Arabia Oncology Based In-Vivo CRO Market revenue, By Indication  , 2015–2025 (USD Billion)
21. South Africa Oncology Based In-Vivo CRO Market revenue, By Indication  , 2015–2025 (USD Billion)
22. Rest of the Middle East & Africa Oncology Based In-Vivo CRO Market revenue, By Indication  , 2015–2025 (USD Billion)
23. Rest of the Middle East & Africa Oncology Based In-Vivo CRO Market revenue, By Mechanism Of Action , 2015–2025 (USD Billion)


 
 

Methodology

FrequentlyAsked Questions

An oncology in-vivo CRO conducts preclinical cancer research. It supports drug testing using live models
The global Global Oncology Based In-Vivo CRO market is expected to be driven by the rising cancer research, increasing clinical trials, and demand for specialized preclinical testing. Outsourcing trends boost market expansion.
According to study, the global Global Oncology Based In-Vivo CRO market size was worth around USD 1.39 Billion in 2023 and is predicted to grow to around USD 3.13 Billion By 2032.
The global Global Oncology Based In-Vivo CRO market is expected to grow at a Compound Annual Growth Rate (CAGR) of around CAGR 8.5% during the forecast period from 2024-2032.
The global Global Oncology Based In-Vivo CRO industry is projected to be challenged by Challenges include complex trial design, high operational costs, and regulatory scrutiny.
The Opportunities include rising oncology R&D, precision medicine growth, outsourcing trends, and demand for specialized preclinical models will offer significant growth opportunities in the Global Oncology Based In-Vivo CRO market.
Advanced animal models and imaging; precision oncology and biomarker-driven studies; digital data capture and analytics are the emerging trends and innovations impacting the Global Oncology Based In-Vivo CRO market.
The global Global Oncology Based In-Vivo CRO market is expected to be led by North America during the forecast period.
Some of the prominent players operating in the global Global Oncology Based In-Vivo CRO market are; Living Tumor Laboratory; EVOTEC; Taconic Biosciences; Charles River Laboratory; Xentech; The Jackson Laboratory; Eurofins Scientific; MI Bioresearch, Inc.; Crown Bioscience; ICON Plc.; Covance; Wuxi AppTec; and Champion Oncology and others.
The report explores crucial aspects of the Global Oncology Based In-Vivo CRO market, including a detailed discussion of existing growth factors and restraints, while also browsing future growth opportunities and challenges that impact the market.
  • zion payment modes

List of Contents

Global Market InsightsIntroductionGlobal Oncology Based In Vivo (CRO) Segmentation AnalysisGlobal Oncology Based In Vivo (CRO) Market, By IndicationGlobal Oncology Based In Vivo (CRO) Market, By ModelGlobal Oncology Based In Vivo (CRO) Market, By GeographyReport ScopeMarket Growth DynamicsNorth America To Contribute Majorly Towards Market Revenue By 2032The global oncology based in-vivo CRO market is segmented as follows:

HappyClients